Probiotics, mainly lactic acid bacteria (LAB), are widely focused on gastrointestinal applications. However, recent microbiome studies indicate that LAB can be endogenous members of other human body sites such as the upper respiratory tract (URT). Interestingly, DNA-based microbiome research suggests an inverse correlation between the presence of LAB and the occurrence of potential pathogens, such as Moraxella catarrhalis, an important URT pathogen linked to otitis media, sinusitis and chronic obstructive pulmonary disease. However, a direct interaction between these microbes has not been explored in detail. This study investigated the direct antipathogenic effects of Lactobacillus species, including several well-documented probiotic strains, on M. catarrhalis using agar-based assays, time course analysis, biofilm assays and minimal inhibitory concentration (MIC) testing. These assays were performed using spent culture supernatans (SCS) at two pHs (4.3 and 7) and D-and/or L-lactic acid at three pHs (2, 4 and 7). In addition, cell line assays for adhesion competition and immunomodulation were used to substantiate the inhibitory effect of lactobacilli against M. catarrhalis. A proportion of Lactobacillus strains, including the model probiotic Lactobacillus rhamnosus GG, showed a strong and direct activity against M. catarrhalis. Screening of the activity of the SCS after different treatments demonstrated that lactic acid has an important antimicrobial activity against this pathogen -at least in vitro -with mean MIC values for D-and L-lactic acid varying between 0.5 and 27 g/l depending on the pH. Furthermore, L. rhamnosus GG also decreased the adhesion of M. catarrhalis to human airway epithelial Calu-3 cells with more than 50%, and the expression of mucin MUC5AC, pro-inflammatory cytokines interleukin (IL)-8, IL-1β, and tumor necrosis factor-α at least 1.2 fold. This study suggests that several lactobacilli and their key metabolite lactic acid are possible candidates for probiotic therapeutic interventions against URT infections. 
Introduction
Moraxella catarrhalis is a Gram-negative pathogen implicated in many airway diseases, such as 15-20% of acute otitis media (OM) infections, 20% of acute sinusitis episodes in children and 10% of the chronic obstructive pulmonary disease exerbations in adults Parameswaran et al., 2009; Rovers et al., 2004) . Interestingly, while the colonisation rate is low in adults (1-5%), M. catarrhalis is a common coloniser of the infant nasopharynx (66-100%) . To treat upper respiratory tract (URT) infections, antibiotics are still considered as standard therapy, while they have many side-effects including the induction of antibiotic resistance (Goossens et al., 2005) . Indeed, a high proportion of M. catarrhalis strains are now resistant to beta-lactam antibiotics such as penicillin and amoxicillin (Harrison et al., 2009) . Moreover, antibiotics disturb the endogenous beneficial microbiota, especially when taken orally. Elimination of key commensal bacteria can facilitate pathogen colonisation in the gastro-intestinal tract and nasopharynx (Tagg and Dierksen, 2003) , resulting in unwanted side-effects such as diarrhea and increased susceptibility to subsequent infections. In addition to pathogen restriction, an intact healthy microbiota plays a key role in the education and function of the immune system (Bogaert et al., 2011; Pettigrew et al., 2012; Stearns et al., 2015) . For all these reasons, an urgent need exists for alternatives to classical antibiotic therapy for infections with Moraxella and other URT pathogens.
In the gastro-intestinal and vaginal tract, probiotic lactobacilli have long been explored as alternatives for antibiotics. Interestingly, several recent microbiome studies have indicated that genera of lactic acid bacteria (LAB) such as Lactobacillus and Lactococcus can also be normal inhabitants of the URT, in variable relative abundances (Bogaert et al., 2011; Pettigrew et al., 2012; Stearns et al., 2015) . In children, a greater abundance of taxa such as Lactococcus and Dolosigranulum (both LABs) appear to be inversely correlated with Moraxella and the risk of developing acute OM (Biesbroek et al., 2014; Pettigrew et al., 2012) . Bogaert and colleagues (2011) observed a marked increase in the absolute incidence of (Brevi)bacillus and Lactobacillus species colonisation in summer (96%) compared to winter (10%) season, the latter of which has the highest prevalence of URT infections. Stearns and colleagues (2015) reported that Lactobacillus strains were present in the nasopharyngeal samples of all 51 healthy children tested with a relative abundance varying between 0.0026 and 5.62%, making it the 13 th most abundant species in that niche. Among the 19 healthy adults included in their study, lactobacilli were even more prevalent, ranked at the 11 th place among commensal species with an abundance varying between 0.0057 and 13.29%. However, these DNAbased microbiome studies have not yet been backed up with mechanistic studies on the direct interactions between LAB and the corresponding URT pathogens. Yet, pilot studies have already shown that the administration of certain LAB could mediate a reduction in the incidence of OM in children (Hatakka et al., 2007; Niittynen et al., 2012; Rautava et al., 2009) . However, until now, most of these probiotics were applied orally in liquid formulas for immune boosting effects, with little attention to the possibility of direct inhibition of URT pathogens by the applied LAB.
In this study, the direct antimicrobial activities of various Lactobacillus strains, including several well-documented probiotic strains, were explored against M. catarrhalis. The analyses were conducted using optimised assays allowing detailed insights in 1:1 competitions between potential probiotic and pathogen.
Materials and methods

Bacterial strains and growth conditions
Lactobacillus strains (Table 1) were grown at 37 °C in de Man, Rogosa and Sharpe (MRS) medium (BD Difco, Erembodegem, Belgium). M. catarrhalis ATCC25238 was inoculated in Mueller Hinton (MH) (LabM Limited, Heywood, UK) broth and cultured aerobically at 37 °C. Solid media contained 1.5% (w/v) agar. For antimicrobial assays, the agar was enriched with glucose (Sigma Aldrich, Steinheim, Germany) to a final concentration of 5 g/l.
Cell culture
The human human airway epithelial cell line Calu-3 ATCC® HTB-55TM (purchased from ATCC, Molsheim Cedex, France) was cultured in 75 cm 2 flasks containing 20 ml Minimum Essential Medium (MEM) (Life Technologies, Erembodegem, Belgium) supplemented with heat inactivated fetal bovine serum (FBS) (Thermo Fischer, Asse, Belgium) and penicillin-streptomycin (100 U/ml) (Life Technologies) and maintained in a humidified 5% CO 2 incubator at 37 °C. The culture medium was changed every 3-4 days and the cells were passaged weekly at a 1:2 split ratio using a 0.25% trypsin-EDTA solution (Life Technologies). For adhesion and immunomodulation experiments, 0.5 ml of Calu-3 cells were seeded in 24-well culture plates at a density of 1.85×10 6 cells/ml. Approximately a week after seeding, confluent monolayers were obtained.
Spot antimicrobial assays with live lactobacilli
The antimicrobial activity of live lactobacilli against the M. catarrhalis was explored by standard antimicrobial tests. The antimicrobial activity of Lactobacillus cultures was explored by modified spot assays (Schillinger and Lücke, 1989) . Briefly, 2 µl of each Lactobacillus culture was spotted on a standard agar plate (1.5% w/v) containing medium of the pathogen supplemented to a final concentration of 5 g/l glucose and a spot of another bacterium was added as negative control. These plates were incubated for 48 h at 37 °C. Ca. 10 6 cfu/ml of the overnight pathogen culture were added to 7 ml of soft agar (0.5% w/v) and poured over the plates with Lactobacillus spots. The plates were incubated overnight at 37 °C, after which time the inhibition zones were measured.
Radial diffusion antimicrobial assay for SCS of lactobacilli
The antimicrobial activity of SCS was investigated with a modified protocol based on previously described competition assays between lactobacilli and gastrointestinal pathogens (Lie et al., 1997) . Approximately 10 6 cfu/ml of M. catarrhalis was added to 60 ml of 1.5% (w/v) agar and poured in a square agar plate. After the plates dried, wholes of 0.4 cm diameter were made in the agar and 30 µl of SCS of lactobacilli was added. The plates were incubated overnight and the inhibition zones were measured. 0.1% hexetidine (Famar Orléans, Orléans, France) and sterile MRS medium brought to pH 4.3 were used as a positive and negative control, respectively. Time-course analysis of the antimicrobial activity of spent culture supernatans
A time-course analysis of the growth inhibition in suspension was performed as described previously (De Keersmaecker et al., 2006) with minor modifications. Briefly, 190 µl of a diluted overnight culture of M. catarrhalis (ca. 10 5 cfu/ml) was added to the wells of a microplate supplemented with 10 µl SCS of lactobacilli to get a total volume of 200 µl. 10 µl 0.1% hexetidine and 10 µl MRS medium at pH 4.3 were used as a positive and negative control, respectively. Bacteria were grown and the OD was measured at 600 nm each 30 min using a Synergy HTX multi-mode reader. Each test was measured at least in triplicate and the average OD was calculated.
Minimal inhibitory concentration assay
The minimal inhibitory concentration (MIC) values were determined based on the procedure described earlier (Nizet et al., 2001) . M. catarrhalis was grown in Mueller Hinton medium as described above. A 96-well plate was filled to get a total volume of 100 µl with a final concentration of 5×10 5 cfu/ml of the pathogen combined with an adequate concentration of the active molecule. The microplate was incubated overnight at 37 °C and the OD at 600 nm was measured.
Biofilm assays
Biofilm formation of the pathogens in the presence of SCS of the lactobacilli was monitored using static biofilm assays. For M. catarrhalis, biofilms were grown as described by Pearson and Hansen (2007) with minor modifications. An overnight culture of M. catarrhalis was diluted 1:100 (±10 5 cfu/ml) in Brain Heart Infusion broth (Difco, BD, Franklin Lakes, NJ, USA). A volume of 190 µl of this suspension was loaded into a 96-well microplate and incubated overnight at 37 °C. To test the antimicrobial activity of the SCS, 10 µl portions of SCS were loaded into the 96-well microplate. 10 µl 0.1% hexetidine and 10 µl MRS medium at pH 4.3 were used as a positive and negative, respectively. After 19 h, the broth was removed from each well and replaced by 200 µl phosphate buffered saline (PBS) plus 10 μl of 0.7% (w/v) crystal violet. After 15 min at room temperature, the wells were emptied and washed three times with deionised water. A 200-µl volume of 95% ethanol was added to each well, and the plate was shaken gently for 15 min. A 150 µl portion of this ethanol solution was then transferred to a new 96-well plate, and the absorbance at 570 nm was measured using a Synergy HTX multi-mode reader.
Adhesion competition assays
The influence of lactobacilli on the adherence of M. catarrhalis to human airway epithelial Calu-3 cells was investigated as described previously (Malik et al., 2013) with minor modifications. Competition tests were carried out by adding a volume of 0.5 ml containing M. catarrhalis (5×10 7 or 5×10 6 cfu) and Lactobacillus rhamnosus GG (5×10 7 cfu) to a tissue culture 24-well plate containing confluent monolayers of epithelial cells, which were allowed to incubate at 37 °C for 1 h to mediate adherence. After incubation, the cells were washed three times with PBS (37 °C) to remove all nonadhering cells and the number of adhering pathogenic cells to the Calu-3 cells was determined by macrodilution method on appropriate agar. Each condition was carried out at least in triplicate.
Induction of cytokine gene expression in Calu-3 epithelial cells
The cytokine response after co-incubation of Calu-3 cells with M. catarrhalis and L. rhamnosus GG was determined as follows. The bacterial strains were first grown overnight and subsequently centrifuged at 2,000×g at 4 °C for 10 min, washed with PBS and resuspended in MEM medium. M. catarrhalis (5×10 7 cfu) was added to the Calu-3 epithelial cells, alone or in presence of L. rhamnosus GG (5×10 7 cfu). After 4 h of incubation, the cells were rinsed thrice with PBS. Next, total RNA was extracted from the Calu-3 cells with RNeasy isolation kit (Qiagen, Hilden, Germany) following the manufacturer's protocol. A constant amount of 1 µg of total RNA was used for oligo-(dT)-primed cDNA synthesis using ReadyScript® reverse transcriptase (Sigma Aldrich). The cytokine gene expression was measurement by quantitative real time polymerase chain reaction (qRT-PCR).
qRT-PCR
Expression of interleukin (IL)-8, IL-1β, mucin MUC5AC and tumour necrosis factor-α (TNF-α) was analysed using Power SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA) according to manufacturer's instructions. Data were quantified with the ΔΔCt method, relative to the reference genes Cytochrome c1 (CYC1) and ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide (ATP5B). Primer sequences can be found in Table 2 . Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines were strictly followed (Bustin et al., 2009) .
Statistics
Data are represented as mean values ± standard deviation. One-way ANOVA and multiple t-tests were used to determine statistical significance in GraphPad Prism (La
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Jolla, CA, USA). The P-value was corrected for multiple comparisons using the Hilm-sidak method in GraphPad Prism. Differences were considered statistically significant at P<0.05.
Results
A proportion of Lactobacillus strains shows antimicrobial activity against M. catarrhalis
The direct interaction between living lactobacilli and M. catarrhalis was tested via spot assays. In these assays, all lactobacilli tested demonstrated a strong activity against M. catarrhalis. Interestingly, several well-known Lactobacillus strains, such as L. rhamnosus GG, Lactobacillus casei Shirota, L. casei DN-114001, Lactobacillus plantarum LMG1284 and L. plantarum WCFS1 were each very active with clear inhibition zones in the range of the positive control 0.1% hexetidine, a common oral antiseptic agent for oropharyngeal infections (Table 3) . As a control, nonLactobacillus microbial species such as Escherichia coli, Haemophilus influenzae and Streptococcus pneumoniae, and the pathogen itself were also included, but expressed no antimicrobial activity against M. catarrhalis.
Subsequently, the activities of the secreted metabolites of the Lactobacillus strains were explored by testing the antimicrobial activity of their respective SCS in radial diffusion assays. The SCS of almost all Lactobacillus strains tested showed a strong activity with inhibition zones larger than 0.5 cm (Table 3) .
Major antimicrobial compound of L. rhamnosus GG against M. catarrhalis is pH-dependent, heat-stable, proteinase K-resistant
To explore this antimicrobial activity of the SCS further, we performed inhibition experiments with the SCS of different Lactobacillus strains, and monitored the growth of M. catarrhalis for 72 h. A prominent strain-specific effect of Lactobacillus SCS and its metabolites against M. catarrhalis was observed ( Figure 1A) . Interestingly, addition of the SCS of the model probiotic strain L. rhamnosus GG inhibited the growth of Moraxella for 72 h to the same extent as the positive control (0.1% hexetidine). This activity was also observed for L. rhamnosus GR-1, L. plantarum CMPG5300 and L. casei ATCC334 but not for slower growing strains exemplified here by L. parabuchneri NM 63-3 ( Figure 1A ). The negative control, i.e. non-inoculated MRS medium brought to pH 4.3, only induced a small delay in growth of M. catarrhalis, indicating that the effect is not merely pH related. Subsequent survival and plate counting assays indicated that the effect of SCS on the growth of M. catarrhalis was bacteriostatic. Since M. catarrhalis often resides within biofilms in infected patients (Perez et al., 2014) , we explored the capacity of SCS of lactobacilli to prevent biofilm formation. As shown in Figure 1B , SCS of L. rhamnosus GG could reduce the biofilm formation of M. catarrhalis up to 70% under the tested conditions. Various other Lactobacillus strains tested such as L. rhamnosus GR-1, Lactobacillus reuteri RC-14, L. casei DN-114001, L. casei Shirota and L. plantarum CMPG5300 also showed the potential to reduce biofilm formation, but their activity appeared less reproducible. For L. casei ATCC334, we could not observe a significant reduction under the tested conditions ( Figure 1B ).
We subsequently aimed to identify the active antimicrobial molecules in the SCS of the lactobacilli, by inactivating or removing different classes of active molecules (acids and proteins). We focused on SCS of L. rhamnosus GG as our model probiotic strain, because this SCS was most active in the experiments described above. The radial diffusion antimicrobial assay showed the antimicrobial activity of SCS of L. rhamnosus GG to be pH-dependent, resistant to proteinase K, and heat-stable, since the inhibition zones only disappeared after neutralising the pH (Figure 2A ). In the time-course analysis, the antimicrobial activity disappeared when the SCS was neutralised to pH 7, both when SCS was added in the beginning of the experiment or after overnight incubation of M. catarrhalis (20 h). In contrast, SCS treated with heat or proteinase K maintained its antimicrobial activity ( Figure 2B) . Additionally, the antibiofilm activity of the SCS was clearly decreased when the pH was neutralised. However, merely pH reduction of MRS medium brought to pH 4.3 by HCl did not significantly affect biofilm formation. Heat and proteinase K-treatment also did not significantly affect the antibiofilm activity ( Figure 2C ).
Lactic acid is an important antimicrobial compound against M. catarrhalis
Since the antimicrobial activity of lactic acid against certain gastro-intestinal Gram-negative pathogens has been previously documented to be pH-dependent (De Keersmaecker et al., 2006) and since the above-described experiments clearly point to acids as active effector molecules, we subsequently explored the role of lactic acid in the inhibition of the Gram-negative pathogen M. catarrhalis. First, we measured the total amount of lactic acid produced in SCS after overnight growth under standard conditions in MRS medium. This amount differed clearly between the various Lactobacillus strains tested as well as the ratio of D-and L-lactic acid. All L. plantarum strains tested produced almost similar amounts of D-and L-lactic acid, while the other Lactobacillus strains tested appeared to produce almost exclusively L-lactic acid ( Figure  3A) . A high pH and low concentration of LA were linked to decreased activity against M. catarrhalis.
To confirm the antimicrobial activity of D-and L-lactic acid, MIC assays were performed against M. catarrhalis. Both D-and L-lactic acid showed a strong activity against M. catarrhalis with an MIC of ca. 0.5 g/l ( Figure 3B ). Interestingly, D-and L-lactic acid were almost 10-fold less active when they were dissolved in a neutral solution, confirming the pH-dependent activity of lactic acid.
Other known more indirect antipathogenic activities of probiotics are competitive exclusion and immunomodulation. Here, we could show that L. rhamnosus GG also inhibited the adhesion of different concentrations of M. catarrhalis to Calu-3 cells ( Figure 4A ). Addition of L. Table 1 .
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Discussion
URT infections mediated by M. catarrhalis in adults and children have a high incidence and thus form a major health threat. Furthermore, they form a common reason for antibiotic prescription in the clinical practice. Yet, unnecessary prescribing of antibiotics is costly, leads to serious unintended side effects, and increases the risk of developing antibiotic resistance (Boatright et al., 2015) . There is thus a clear need for alternatives for antibiotic therapy and prevention, particularly against Gram-negative pathogens (Wenzler et al., 2016) . Since pioneering microbial profiling studies have suggested correlations between the occurrence of LAB and reduced risk of URT infections, the use of probiotic lactobacilli in the fight against URT infections holds promise. In this study, we have shown for the first time -to the best of our knowledge -detailed data supporting a direct antimicrobial role for lactobacilli against a main URT pathogen, M. catarrhalis.
Our results show a clear potential for several Lactobacillus strains to inhibit the growth of M. catarrhalis in suspension and as biofilm. Furthermore, L. rhamnosus GG was shown to compete with M. catarrhalis for adhesion to human airway epithelial Calu-3 cells and decrease the gene expression of IL-1β, IL-8, MUC5AC and TNF-α. Both actively growing lactobacilli and their secreted metabolites in SCS showed a clear direct antimicrobial activity against M. catarrhalis in agar-based assays. As to the identification of active compounds, acids appeared to play a major role in the inhibition of the pathogen, since the activity disappeared after neutralising the pH. Furthermore, a link was found between the concentration of lactic acid in the SCS and 
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Most lactobacilli are homofermentative LAB that produce D-and/or L-lactic acid. To investigate the importance of both isomers in the antimicrobial activity of the Lactobacillus species, MIC assays were performed. We observed a MIC varying between 0.5 and 27 g/l depending on the pH for L-and D-lactic acid. These MIC values are higher than the MIC of 16 mg/l for amoxicillin, a common used antibiotic for URT infections (Harrison et al., 2009) . However, these values should be considered in the context of the human microbiota where live bacteria interact and where applied probiotics could continuously secrete lactic acid as a consequence of their metabolism when alive. Since previous microbiome profiling studies have documented that various Lactobacillus OTUs can be present in several individuals in relative amounts up to 13.29% in the URT niche (Abreu et al., 2012; Bogaert et al., 2011; Laufer et al., 2011; Stearns et al., 2015) , a local production of lactic acid, or antimicrobial compounds in general, could be sufficient to compete in a direct way with the associated pathogens. In this way, a bacteriostatic activity could preserve the microbial balance in this niche and prevent overgrowth of unwanted pathogens. It is important to note that the MIC values of lactic acid against M. catarrhalis were found here to significantly increase with increasing pH. As previously ascertained for the pathogens E. coli, Pseudomonas aeruginosa and Salmonella enterica serovar Typhimurium (Alakomi et al., 2005) , the undissociated form of lactic acid appears to be most active also against the Gram-negative pathogen M. catarrhalis.
Although we could clearly substantiate an antimicrobial role for lactic acid against M. catarrhalis in our present work, possible activity of additional molecules can not be ruled out. These other molecules seem heat-resistant and pH-dependent based on the agar-based antimicrobial and biofilm assays and could have synergistic effects with lactic acid. However keeping in mind that the agar-based assays used in this study favour the identification of small active molecules, due to differences in diffusion velocities as described by Bonev et al. (2008) , the involvement of other molecules cannot be ruled out. For example, Niku-Paavola et al. (1999) observed an inhibitory substance, the cyclic molecule mevalonolactone, in the SCS of L. plantarum VTT E-78076 which activity increased from 15 to 60% inhibition in the presence of 1% lactic acid (activity 40%). Such synergistic effects are likely secondary to the possible permeabilisation of the membrane by lactic acid. In addition, we could recently demonstrate an antibiofilm activity of lectin-like proteins of L. rhamnosus GG against other Gram-negative pathogens (Petrova et al., 2016) pointing to additional antimicrobial mechanisms of lactobacilli.
More indirect activities such as competition for adhesion sites and nutrients (competitive exclusion) and modulations of the immune system are also postulated to be key factors in the antimicrobial potential of probiotics (Lebeer et al., 2008) . In this study, in addition to its direct antimicrobial effect, the effect of L. rhamnosus GG on adhesion and pro-inflammatory gene expression in Calu-3 cells by M. catarrhalis was therefore investigated. L. rhamnosus GG significantly dampened the gene expression of IL-1β, IL-8 and TNF-α after incubation with Moraxella. In addition, the gene expression of MUC5AC, a mucin commonly correlated with OM (Kerschner et al., 2010) , was significantly reduced. Especially in the URT, mucin production can be problematic and correlated with pathogens as they benefit from the increased nutrient availability and adherence possibility. Also Abreu et al. (2012) demonstrated in a mouse model that another URT pathogen (Corynebacterium tuberculostearicum) significantly increased the mucin secretion in the host, which could be attenuated in the presence of Lactobacillus sakei. The importance and exact molecular signalling events in the activity of lactobacilli against mucin hypersection remains however to be further explored.
To conclude, we have documented in this study that several Lactobacillus species show antimicrobial activities against M. catarrhalis. Local application of probiotic bacteria could thus have potential as a therapeutic or preventive strategy against URT infections in which this pathogen is involved. However, before such therapies will be feasible, clinical studies in humans will have to confirm our findings.
